Groundbreaking £1.65m gene-editing therapy approved for NHS use offers hope to severe sickle cell patients
A £1.65 million treatment has been approved for use by some NHS patients, offering hope of a cure to those with an inherited blood disorder. Health officials have given the green light to a gene-editing therapy for certain children and adults suffering …